Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.

Acta neurologica Scandinavica(2018)

引用 9|浏览20
暂无评分
摘要
In view of its good tolerability, (-)-OSU6162 may offer a new treatment option for alleviating mental fatigue, as well as depression, in MS. Larger, randomized double-blind controlled trials are warranted to confirm the present preliminary observations.
更多
查看译文
关键词
fatigue,monoaminergic stabilizer,mood,multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要